RecruitingACTRN12613001117707

Predilution online hemodiafiltration with Citrasate - is it a possible option for heparin free procedure?

Citrate acid concentrate Citrasate for online predilution hemodiafiltration in patients on maintenance hemodialysis as an alternative of anticoagulation free procedure - comparison with acetate-based concentrate.


Sponsor

Pavlina Richtrova, M.D., Ph.D.

Enrollment

10 participants

Start Date

Sep 13, 2013

Study Type

Interventional

Conditions

Summary

We want to test the hypothesis, 4 hr online predilution HDF with Citrasate is possible to be realized without manifest clotting problems even with no anticoagulation therapy. As a secondary outcome we want to describe coagulation cascade activation based on TAT concentration during this HDF procedure.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether kidney dialysis patients can safely undergo a 4-hour treatment session called online hemodiafiltration (a very effective form of dialysis that cleans the blood more thoroughly) without needing any blood-thinning medication (anticoagulation). The special dialysis fluid used — called Citrasate — may naturally help prevent clotting in the machine during the procedure. Researchers will check whether the treatment can be completed safely and will measure markers in the blood that show whether clotting was triggered. You may be eligible if: - You have end-stage chronic kidney disease (stage 5) and have been on dialysis for more than 3 months - You have a functioning arteriovenous fistula (a connection created in your arm for dialysis) that provides good blood flow - You are 18 years of age or older - You are male or female You may NOT be eligible if: - You have liver disease (elevated liver enzymes more than double the normal limit) - You have a bleeding or clotting disorder, or a low platelet count (below 100,000) - You are on any blood-thinning medication other than aspirin - You have cancer Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

In a random order patients undergo one 4 hr procedure of online predilution hemodiafiltration with acetic acid or citrate acid (Citrasate) concentrate respectively. In two weeks and in a cross-over ma

In a random order patients undergo one 4 hr procedure of online predilution hemodiafiltration with acetic acid or citrate acid (Citrasate) concentrate respectively. In two weeks and in a cross-over manner they undergo the second study procedure with citrate or acetic acid respectively. Citrate concentration in Citrasate is 0,8 mmol/l.


Locations(1)

Czech Republic

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613001117707